Navigation Links
KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization
Date:9/16/2013

ny motions filed in the bankruptcy court and/or any appeal of actions of the bankruptcy court;
(2)        the effects of the Chapter 11 cases on the Company and the other debtors, including their liquidity or results of operations, and the interests of various creditors, equity holders and other constituents;
(3)        the ability to execute the Company's business plan;
(4)        the ability of the Company to meet its obligations under the First Lien Secured Term Loan Facility dated September 13, 2013; and
(5)        the ability of the Company and the other debtors to maintain contracts that are critical to their operation, including to obtain and maintain normal terms with their vendors, customers and service providers and to retain key executives, managers and employees.

This discussion is not exhaustive, but is designed to highlight important factors that may impact our forward-looking statements.

Because the factors referred to above, as well as the statements included in Part I, Item 1A —"Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended March 31, 2012, the statements under the heading "Risk Factors" in our Registration Statement on Form S-1 filed with the SEC on July 31, 2012, and the statements included in Article XI — "Certain Risk Factors to be Considered" of the Disclosure Statement for the confirmed Plan, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by us or on our behalf, you should not place undue reliance on any forward-looking statements. All forward-looking statements attributable to us are expressly qualified in their entirety by the cautionary statements in this "Cautionary Note Regarding Forward-Looking Statements" and the risk factors that are included under Part I,
'/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... -- Hospira, Inc. (NYSE: HSP ), the ... technologies, today reported results for the second quarter ... quarter were $1.1 billion and adjusted* diluted earnings ... items as described later in this press release ... Accepted Accounting Principles (GAAP) basis, second-quarter 2014 diluted ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014 /PRNewswire/ ... held biotech company that designs and develops novel ... management of cancer, announced today the completion of ... The financing included new investors RusnanoMedInvest (RMI) and ... Fund, and Pfizer Venture Investments, as well as ...
(Date:7/30/2014)... 30. Juli 2014 Die Apex ... Anbieter im Bereich Atemtherapie- und Druckzonenprodukte, gibt ... München in Deutschland anfechten werden. Dieses hat ... ein Patent von ResMed verletze. Apex weist ... Ländern gegen verschiedene Patente von ResMed Anfechtungen ...
Breaking Medicine Technology:Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3
... Sept. 23 Surefil, a contract manufacturer of liquid-fill ... medical industries, and energy drinks, emerged from Chapter 11 ... The company was able to attract ABACO Partners, LLC ... Executive Officer of Universal Forest Products, Bill Currie, to ...
... Netherlands, Sept. 23 DuPont (NYSE: DD ... form a joint venture to develop, manufacture and commercialize ... The joint venture will be named Actamax Surgical Materials ... will each share a 50 percent interest. The ...
Cached Medicine Technology:Surefil Emerges from Chapter 11 2DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 2DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 3DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials 4
(Date:7/30/2014)... elderly American adults is being financially exploited often ... crisis especially affects poor and black people. It merits ... citizen who cares about the dignity and well-being of ... Medical College in the US. She led one of ... findings of which appear in the Journal of ...
(Date:7/30/2014)... hospital in Ireland has shown than many of them did ... the risk of entrapment. The report, published online in the ... for careful selection of patients for whom bedrails are to ... maintenance of hospital bed systems. , Bedrails are commonly used ... although the risk for any individual is extremely low, people ...
(Date:7/30/2014)... The report entitled “Global Pulse Oximetry Market: Trends ... dynamics and changing trends in the global pulse oximetry ... sizing of the global pulse oximetry market and also ... same. It further captures the global market share based ... Further, the report discusses the domestic market of United ...
(Date:7/30/2014)... Los Angeles cosmetic dentist , ... that can help patients create their dream smiles at ... gums form the foundation of smile confidence, but cosmetic ... misshapen teeth or stains may not interfere with dental ... The right cosmetic treatments can eliminate chips, erase stains ...
(Date:7/30/2014)... July 30, 2014 Building ENT and ... allergy, and audiology practice in Westchester County takes the ... technology, a superb underlying corporate structure and protocols, and ... also takes a leading Chief Financial Officer to help ... (WCBJ), that’s exactly what it possesses. In fact, in ...
Breaking Medicine News(10 mins):Health News:Older adults are at risk of financial abuse 2Health News:High frequency of potential entrapment gaps in hospital beds 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 2Health News:Global Pulse Oximetry Market 2018 Opportunities and Trends Now Available at MarketReportsOnline.com 3Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 2Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, Now Offers Comprehensive Cosmetic Dental Treatments 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3
... BAYFIELD, Colo., July 14 Kanakuk Colorado today released the ... illness. , , "Yesterday, Kanakuk ... that at 2:00 p.m. on Saturday afternoon 2 campers presented to ... throats. Within 30 minutes these campers had been isolated from the ...
... , , , ... an older adult can easily turn into a downward slide into a ... health care for the elderly, Aurora Health Care is sponsoring a continuing ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ) , ...
... BINGHAM FARMS, Mich., July 14 United Physicians ... 1st, 2009. The decision to take a more eco-friendly ... faxes that have historically been used to communicate with the ... "The decision to ,Go Green, with our business communications ...
... HAYWARD, Calif., July 14 Solta Medical, Inc. (Nasdaq: ... today announced that it will release its financial results for the ... Thursday, July 30, 2009. The Company will also host a ... p.m. Eastern Time (1:30 p.m. Pacific) to discuss the financial results ...
... MIAMI and SAN DIEGO, July 14 Sorrento ... for the generation of fully human monoclonal antibodies, and QuikByte ... no active operations, have signed a merger agreement pursuant to ... QuikByte. After the merger is completed, QuikByte will be ...
... compliance, study finds , TUESDAY, July 14 (HealthDay News) -- ... use of a reminder program for women who were due ... Permanente staff checked electronic health records of its 35,000 members ... a mammogram for 20 months. They were sent a postcard ...
Cached Medicine News:Health News:Statement for Attribution to Andy Braner, President, Kanakuk Colorado, Bayfield CO 2Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 2Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 3Health News:Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 4Health News:United Physicians Goes Green Effective August 1st, 2009 2Health News:Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 2Health News:QuikByte Software, Inc. and Sorrento Therapeutics, Inc. Announce Merger Agreement 3Health News:Reminders Boost Mammography Appointments 2
... bench style refrigerator (can be situated on or ... of bags is to be stored as in ... white colorbond steel while the interior is a ... door is key lockable. Control panel is flush ...
The Testosterone Enzyme Immunoassay is intended for the quantitative determination of Testosterone concentration in human serum. No special pretreatment of the sample is necessary. For in vitro Diag...
DSL-10-49300 is a rapid, direct enzyme immunoassay (EIA) kit that provides materials for the quantitative measurement of testosterone in saliva. This assay requires no sample extraction or pretreat...
... This HPLC for Vitamin B6 makes ... an easy, fast and precise method. The ... form for preparation and separation of the ... of HPLC analytics is the simultaneous handling ...
Medicine Products: